Dan Kaufman

Dan Kaufman

Company: Shoreline Biosciences; UC- San Diego

Job title: CSO & Professor

Seminars:

Panel Discussion: Is Gene Editing Truly the Key to Unlocking the Power of iPSC-Derived Cell Therapy Products? 5:00 pm

Investigating the need for genetically removing self-antigens for development of a true allogeneic, universal iPSC immune product Creating immunological space for iPSC derived immunotherapies by carrying out lymphodepletion How to gene modify a universal graft without losing the function of the graftRead more

day: Day One

Engineering iPSCs to Derive Immune Cells with Improved Functions 4:00 pm

Strategies to engineer iPSCs with novel receptors or genetic deletions as a key platform to produce NK cells and macrophages with improved anti-tumor activity Describe how iPSC-derived NK cells and macrophages may work together to mediate improved anti-tumor activityRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.